KONGENS LYNGBY, Denmark, Aug. 5, 2025 /PRNewswire/ -- Aquaporin has successfully completed the Living Lab Project to develop the world's first biomimetic low-energy Aquaporin...
The digital therapeutics market is anticipated to increase due to the growing global burden of chronic conditions such as diabetes, cardiovascular disorders, and obesity...
The digital therapeutics market is anticipated to increase due to the growing global burden of chronic conditions such as diabetes, cardiovascular disorders, and obesity...
Build real-world resilience with a simple, category-based system that covers emergency food, portable water filtration, solar power, and off-grid heating—designed for modern families facing blackouts, disasters, or disruptions in 2025.
Build real-world resilience with a simple, category-based system that covers emergency food, portable water filtration, solar power, and off-grid heating—designed for modern families facing blackouts, disasters, or disruptions in 2025.
NEWARK, Del., Aug. 1, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce Project Call 9.1 for...
Delivers strong margin expansion and adjusted EPS growth for FY25 despite challenging environment in the second half of the fiscal year
OAKLAND, Calif., July...
GLEN ALLEN, Va., July 30, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) (The Company) today announced results for the second quarter of 2025.
Second Quarter...
WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1
Explore the PFAS Filtration Companies Quadrant, a comprehensive study revealing key players like Veolia, AECOM, and Xylem leading the global PFAS filtration market. As environmental concerns over per-and polyfluoroalkyl substances (PFAS) rise, driven by their widespread use and environmental impact, effective filtration solutions become crucial. The industry's growth is fueled by regulatory mandates and public health concerns. Key technologies include activated carbon adsorption, reverse osmosis, and ion exchange resins, with municipalities and sectors like aerospace investing heavily in PFAS solutions. Discover the top 15 companies shaping this rapidly growing market.
Explore the PFAS Filtration Companies Quadrant, a comprehensive study revealing key players like Veolia, AECOM, and Xylem leading the global PFAS filtration market. As environmental concerns over per-and polyfluoroalkyl substances (PFAS) rise, driven by their widespread use and environmental impact, effective filtration solutions become crucial. The industry's growth is fueled by regulatory mandates and public health concerns. Key technologies include activated carbon adsorption, reverse osmosis, and ion exchange resins, with municipalities and sectors like aerospace investing heavily in PFAS solutions. Discover the top 15 companies shaping this rapidly growing market.